CSI Market
Sign In | Register

Savient Pharmaceuticals Inc (SVNT) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SVNT quarterly Cash Flow →
This cash flow overview for Savient Pharmaceuticals Inc spans from to Dec 31 2012, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2012)
12 Months 		(Dec 31 2011) (Dec 31 2008) (Dec 31 2012)
Operating Activities
Income-118.31
Depreciation & amortization0.85
Amortization of Other Assets13.08
Increase (Decrease) in Deferred Revenue12.48
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-6.60
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation6.93
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants21.86
Change In Fair Value Of Warrant Liabilities-2.35
Income taxes46.30
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.40
Increase (Decrease) in Accounts Payable-3.61
Increase (Decrease) in Interest Payable, Net-1.49
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.01
Other Working Capital2.46
Other Noncash Income (Expense)0.00
Other net-2.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-114.75
Investing Activities
Capital Expenditures-1.68
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Held-to-maturity Securities66.45
Payments to Acquire Held-to-maturity Securities-56.71
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash-0.15
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.30
Discontinued operations0.00
Net Cash Flow from Investing Activities8.22
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings42.65
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.50
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock For Cash On Registered Direct Offering Net-
Stock Repurchased And Retired During Period Value-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities43.15
Effect of exchange rate on cash flow-0.38
Discontinued operations0.00
Free Cash Flow-116.42
Total Cash Flow-63.76
4 historic quarters locked

Sign in to unlock the full Savient Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About SVNT Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License